Hepatitis C virus infection and related risk factors among injection drug users in montenegro

European Addiction Research

Volumn 19, Issue 2, 2013, Pages 68-73

  Baćak, Valerio ^a,b   Laušević, Dragan ^c   Mugoša, Boban ^c   Vratnica, Zoran ^c   Terzić, Nataša ^c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Institute of Public Health   (Montenegro)

Author keywords

Hepatitis C virus; Injection drug users; Respondent driven sampling; Southeastern Europe

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DRUG DEPENDENCE; FEMALE; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MONTENEGRO (REPUBLIC); PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; VIRUS DIAGNOSIS; DRUG USE; HEPATITIS C VIRUS; INFECTION PREVENTION; INJECTION DRUG USER; VULNERABLE POPULATION;

ADULT; DRUG USERS; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MONTENEGRO; PROSPECTIVE STUDIES; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84866520285     PISSN: 10226877     EISSN: 14219891     Source Type: Journal    
DOI: 10.1159/000339840     Document Type: Article

References (28)

1. Aceijas C, Stimson GV, Hickman M, Rhodes T: Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 2004; 18: 2295-2303.
2. Hamers FF, Downs AM: HIV in central and eastern Europe. Lancet 2003; 361: 1035-1044.
3. Kelly JA, Amirkhanian YA: The newest epidemic: A review of HIV/AIDS in central and eastern Europe. Int J STD AIDS 2003; 14: 361-371.
4. Rhodes T, Simic M: Transition and the HIV risk environment. BMJ 2005; 331: 220-223.
5. Cohen J: Late for the epidemic: HIV/AIDS in eastern Europe. Science 2010; 329: 160-164.
6. Kruglov YV, Kobyshcha YV, Salyuk T, Varetska O, Shakarishvili A, Saldanha VP: The most severe HIV epidemic in Europe: Ukraine's national HIV prevalence estimates for 2007. Sex Transm Infect 2008; 84: 37-41.
7. Platt L, Bobrova N, Rhodes T, Uusküla A, Parry JV, Rüütel K, Talu A, Abel K, Rajaleid K, Judd A: High HIV prevalence among injecting drug users in Estonia: Implications for understanding the risk environment. AIDS 2006; 20: 2120-2123.
8. Rhodes T, Platt L, Maximova S, Koshkina E, Latishevskaya N, Hickman M, Renton A, Bobrova N, McDonald T, Parry JV: Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: A multi-city study. Addiction 2006; 101: 252-266.
9. Shapatava E, Nelson KE, Tsertsvadze T, del Rio C: Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia. Drug Alcohol Depend 2006; 82: 35-38.
10. Djurić D: The economic development of Montenegro; in Bieber F (ed): Montenegro in Transition: Problems of Identity and Statehood. Baden-Baden, Nomos Verlagsgesellschaft, 2003, pp 139-158.
11. Judd A, Rhodes T, Johnston LG, Platt L, Andjelkovic V, Simić D, Mugosa B, Simic M, Zerjav S, Parry RP, Parry JV: Improving survey methods in sero-epidemiological studies of injecting drug users: A case example of two cross sectional surveys in Serbia and Montenegro. BMC Infect Dis 2009; 9: 14.
12. Heckathorn DD: Respondent-driven sampling: A new approach to the study of hidden populations. Social Problems 1997; 44: 174-199.
13. Heckathorn DD: Respondent-driven sampling II: Deriving valid population estimates from chain-referral samples of hidden populations. Social Problems 2002; 49: 11-34.
14. Heckathorn DD: Extensions of respondentdriven sampling: Analyzing continuous variables and controlling for differential recruitment. Sociol Methodol 2007; 37: 151-207.
15. Rácz J, Gyarmathy VA, Neaigus A, Ujhelyi E: Injecting equipment sharing and perception of HIV and hepatitis risk among injecting drug users in Budapest. AIDS Care 2007; 19: 59-66.
16. Longshore D, Stein JA, Conner BT: Psychosocial antecedents of injection risk reduction: A multivariate analysis. AIDS Educ Prev 2004; 16: 353-366.
17. Cazin I, Pristaš I, Kolarić B: Knowledge and attitudes of physicians about HIV/AIDS in primary health care practice Y a pilot study in the city of Zagreb and the Zagreb county; in Gjenero-Margan I, Kolarić B (eds.): Second Generation of Surveillance in HIV Infection and AIDS in the Republic of Croatia, 2003-2006. Zagreb, Croatian National Institute of Public Health, 2006, pp 34-56.
18. Aceijas C, Rhodes T: Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 2007; 18: 352-358.
19. Richardson L, Sherman SG, Kerr T: Employment amongst people who use drugs: A new arena for research and intervention? Int J Drug Policy 2012; 23: 3-5.
20. Folch C, Casabona J, Brugal MT, Majó X, Esteve A, Merono M, Gonzalez V, REDAN Study Group: Sexually transmitted infections and sexual practices among injecting drug users in harm reduction centers in Catalonia. Eur Addict Res 2011; 17: 271-278.
21. Miller CL, Johnston C, Spittal PM, Li K, Laliberté N, Montaner JSG, Schechter MT: Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology 2002; 36: 737-742.
22. Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D: Correlates of HIV infection among young adult short-term injection drug users. AIDS 2000; 14: 717-726.
23. Rhodes T, Treloar C: The social production of hepatitis C risk among injecting drug users: A qualitative synthesis. Addiction 2008; 103: 1593-1603.
24. Sarang A, Rhodes T, Sheon N, Page K: Policing drug users in Russia: Risk, fear, and structural violence. Subst Use Misuse 2010; 45: 813-864.
25. Maher L, Dixon D: Policing and public health: Law enforcement and harm minimization in a street-level drug market. Br J Criminol 1999; 39: 488-512.
26. Bourgois P, Prince B, Moss A: The everyday violence of hepatitis C among young women who inject drugs in San Francisco. Hum Organ 2004; 63: 253-264.
27. Paquette D, Bryant J, de Wit J: Respondentdriven sampling and the recruitment of people with small injecting networks. AIDS Behav 2012; 16: 890-899.
28. Haasen C, Verthein U, Eiroa-Orosa FJ, Schäfer I, Reimer J: Is heroin-assisted treatment effective for patients with no previous maintenance treatment? Results from a German randomised controlled trial. Eur Addict Res 2010; 16: 124-130.